Publications

Hogan Lovells Publications

Insurance Horizons 2018

As a global insurance industry team, we aim to follow industry trends and developments as closely as possible in order to deliver well informed perspectives and thought leadership to our...

Hogan Lovells Publications

Connecting Europe - False advertising in life sciences

In view of the success of our first edition of “False Advertising in Life Sciences”, we are proud to introduce our second edition which is even more thorough.

Hogan Lovells Publications

A road map to successful life sciences transactions in Europe

U.S. based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions.

Brochures

You can bet on us: Our international service and experience in the gaming industry

This brochure shows regulatory and administrative challenges in the domestic market but also advises on market entry strategies and regulatory requirements in other jurisdictions: The...

Published Works

The British Aggregates saga - Looking back at an earlier stage of the selectivity discussion

Clemens Ziegler authored a contribution to the chapter on the British Aggregates case, titled "The British Aggregates Saga – Looking Back at an Earlier Stage of the Selectivity...

Hogan Lovells Publications

The connected car: How European data protection, smart transport systems, and competition law intersect

In this hoganlovells.com interview, partner Winston Maxwell and counsel Gianni De Stefano discuss how European data protection, smart transport systems, and competition law intersect and...

Hogan Lovells Publications

The EU regulatory challenges and liability risks associated with 3-D printed medical devices

In this hoganlovells.com Q&A, Hogan Lovells counsel Fabien Roy addresses EU regulations that apply to medical devices that are produced using 3-D printing technologies.

Publications

China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry

On 14 August 2017, the National Development and Reform Commission ("NDRC") released a draft of the Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active...

;
Loading data